Stock Screener
US stocks rated by the Lician Quant model: a 1–5 rating and A+ to F grades for valuation, growth, profitability, momentum and EPS revisions, each against the stock’s sector. Filter, sort by any factor and share the URL.
5 stocks · Strong Buy or Buy · Healthcare · Dividend yield ≥ 2%
| Stock | Quant ratingRating | ValuationVal | GrowthGrow | ProfitabilityProf | MomentumMom | EPS revisionsRev | Market capMkt cap | P/EP/E | Revenue growthRev YoY | Div. yieldYield | Short % floatShort | Next earningsEarnings |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1AMGNAmgen Inc | 4.76Strong Buy | B | B- | A+ | A | C+ | $250B | 28.6 | +9.1% | 2.80% | 2.5% | — |
| 2GSKGlaxoSmithKline PLC ADR | 4.72Strong Buy | A | B | A | C- | — | $99.3B | 13.2 | +7.4% | 3.50% | 0.4% | — |
| 3NRCNational Research Corp | 4.42Buy | B- | C | A- | A+ | C+ | $452M | 77.2 | -0.2% | 3.03% | — | — |
| 4UNHUnitedHealth Group Incorporated | 4.35Buy | A | C- | A- | B- | B | $364B | 25.8 | +6.5% | 2.17% | — | — |
| 5CICigna Corp | 4.03Buy | A+ | B- | B- | B- | D | $78.2B | 12.2 | +7.8% | 2.23% | 2.6% | Nov 5 |
Showing 5 of 5
Source: Lician Quant Grades (SEC EDGAR statements, EODHD prices and estimates); short interest: FINRA; earnings dates: earnings calendar; dividend yield: EODHD fundamentals · Quant run Nov 4, 2026
Grades rank each stock against its sector peers; they are not investment advice. How the rating and grades work · Short interest · Earnings calendar